![Raymond Urbanski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Raymond W.
Urbanski founded CSA, Inc., where he worked as President.
Dr. Urbanski also currently works at Suntory Pharmaceutical, Inc., as Chief Medical Officer, VP-Research & Development.
Dr. Urbanski also formerly worked at GT Biopharma, Inc., as Chairman, President, CEO & Chief Medical Officer from 2018 to 2019, Aventis SA, as Senior Director-US Medical Affairs, Applied BioSciences Corp., as Director in 2020, Pfizer Inc., as Vice President & Medical Head-Established Products from 2008 to 2012, CymaBay Therapeutics, Inc., as Chief Medical Officer from 2011 to 2012, MannKind Corp., as Chief Medical Officer & Vice President from 2015 to 2017, Mylan, Inc., as Chief Medical Officer from 2012 to 2014, and Suntory Pharmaceutical Research Laboratories LLC, as Chief Marketing Officer.
Dr. Urbanski received his doctorate degree from the University of Medicine & Dentistry of New Jersey and doctorate degree from New Jersey Medical School.
Postes actifs de Raymond Urbanski
| Sociétés | Poste | Début |
|---|---|---|
Suntory Pharmaceutical, Inc. | Directeur Technique/Scientifique/R&D | - |
CSA, Inc. | Fondateur | - |
Anciens postes connus de Raymond Urbanski
| Sociétés | Poste | Fin |
|---|---|---|
| APPLIED BIOSCIENCES CORP. | Directeur Général | 11/03/2020 |
| GT BIOPHARMA, INC. | Directeur Général | 15/03/2019 |
| MANNKIND CORPORATION | Directeur Technique/Scientifique/R&D | 29/09/2017 |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/09/2014 |
| CYMABAY THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2012 |
Formation de Raymond Urbanski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
GT Biopharma, Inc.
 GT Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovering, developing and commercializing novel therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
MannKind Corp.
 MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Applied BioSciences Corp.
 Applied BioSciences Corp. Pharmaceuticals: OtherHealth Technology Creates cannabinoid products that promote healing, health and wellness | Health Technology |
University of Medicine & Dentistry of New Jersey
 University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSA, Inc. | |
Suntory Pharmaceutical Research Laboratories LLC | |
New Jersey Medical School
 New Jersey Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suntory Pharmaceutical, Inc. |
